Functional Social Support in COPD Self-Management
Part of paid clinical trials in Charleston, South Carolina.
- Sponsor
- Medical University of South Carolina
- Study ID
- NCT07353034
- Status
- Recruiting
Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This observational study aims to examine how different types of functional social support (emotional/informational, tangible, affectionate, and positive social interaction) predict self-management capacity among individuals with chronic obstructive pulmonary disease (COPD). The study includes a quantitative cross-sectional survey and qualitative semi-structured interviews (N=20) to explore barriers and facilitators to adequate social support. Findings will inform the development of targeted self-management interventions for COPD patients.
Key Dates
- Start date
- Sep 26, 2025
- Status verified
- Jan 2026
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 111 participants (estimated)
Arms
- Arm: COPD Adults (≥40 years)Adults aged 40 years and older with a self-reported diagnosis or treatment for chronic obstructive pulmonary disease (COPD). All participants will complete an online survey; a subset will participate in qualitative interviews.
Primary Outcome Measure
Self-management capacity [ Time Frame: At enrollment (single time point) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical University of South Carolina | Charleston | South Carolina | 29425 |
Find similar trials in Charleston, SC
By research site
Related Studies
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)PHASE3 · Recruiting · AstraZeneca · Cullman, Alabama
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)PHASE3 · Recruiting · AstraZeneca · Foley, Alabama
- A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseasePHASE2 · Recruiting · AstraZeneca · Birmingham, Alabama
- Collection of Airway, Blood and/or Urine Specimens From Subjects for Research StudiesRecruiting · Weill Medical College of Cornell University · New York, New York